List of projects qualified for funding in NCN call EXPRESS CALL TO FUND RESEARCH ON COVID-19

  • Coordinator: Dr inż. Tomasz Szumełda
  • Date of call announcement: 30th March, 2020

lp.Project titlePrincipal InvestigatorName of entityRequested funds (PLN)Granted funds (PLN)Panel
1.SARS-CoV-2 mRNA capping machinery – studies on nsp14 and nsp16 methyltransferase activity using high-throughput fluorescence methoddr hab. Jacek Jemielity, prof. UWUniwersytet Warszawski769 200769 200ST4
2.Retargeting of known drugs towards proteases involved in the development of COVID-19 diseaseprof. dr hab. Marcin DrągPolitechnika Wrocławska1 590 0001 590 000NZ1
3.Potential SARS-Cov-2 antiviral strategy based on the inhibition of programmed ribosomal dr hab. Joanna  KufelUniwersytet Warszawski877 920877 920NZ1
4.SARS-CoV-2 RNA, target for inhibition of virus replicationprof. dr hab. Elżbieta KierzekInstytut Chemii Bioorganicznej Polskiej Akademii Nauk1 026 000990 000NZ6
5.Determination of the 3D structure of key regulatory regions at the 5' and 3' termini of SARS-CoV-2 RNA and identification of small molecule compounds that prevent the formation of these structuresprof. dr hab. Janusz Bujnicki, czł. koresp. PANMiędzynarodowy Instytut Biologii Molekularnej i Komórkowej w Warszawie999 000951 000NZ1
6.Peptide foldamer-based inhibitors of human ACE2 – SARS-CoV-2 S protein interactiondr hab. Łukasz BerlickiPolitechnika Wrocławska465 600465 600ST4
7.iCovid, impedimetric platform based on boron-doped diamond nanostructures for quantitative analysis of virus-receptor interactionsdr hab. Robert Bogdanowicz, prof. PGPolitechnika Gdańska1 096 200536 400ST7
8.Involvement of cell-surface vimentin in SARS-CoV-2 cell entryprof. dr hab. Robert BuckiUniwersytet Medyczny w Białymstoku514 560514 560NZ6
9.The impact of the COVID-19 pandemic on engagement in solving collective problemsdr Katarzyna JaśkoUniwersytet Jagielloński352 800352 800HS6
10.Ethics of clinical trials in COVID-19 pandemicdr hab. Marcin  Waligóra, prof. UJUniwersytet Jagielloński244 800244 800HS1
11.Elucidation and treatment of a cytokine storm syndrome as an approach to combat fatal complications of COVID-19prof. dr Marcin MyckoUniwersytet Warmińsko-Mazurski w Olsztynie1 080 0001 080 000NZ6
12.dr hab. Ewelina KrólUniwersytet Gdański999 600999 600NZ6
13.Evaluation of the role of inflammasome in the pathogenesis of COVID-19- establishment of in vitro experimental platform.dr Tomasz SkireckiCentrum Medyczne Kształcenia Podyplomowego406 800406 800NZ6
14.Validation of PDB models of potential drug design targets for SARS-CoV-2 coronavirusprof. dr hab. Mariusz JaskólskiInstytut Chemii Bioorganicznej Polskiej Akademii Nauk384 000384 000NZ1
15.Rapid and operationally simple SARS-CoV-2 tests using CRISPR toolsprof. dr hab. Matthias BochtlerInstytut Biochemii i Biofizyki Polskiej Akademii Nauk243 085243 085NZ1
16.Health behavior change during COVID-19 pandemic: the focus on handwashingprof. dr hab. Aleksandra ŁuszczyńskaSWPS Uniwersytet Humanstycznospołeczny297 840297 840HS6
17.SARS-CoV-2 papain-like protease: inhibition of a viral processing and deubiquitinating enzyme – comprehensive in silico approachdr hab. Joanna Sułkowska, prof. UWUniwersytet Warszawski135 240135 240NZ7
18.TMPRSS2 – a potential new drug target and a determinant of COVID19 outcomedr Paweł ZmoraInstytut Chemii Bioorganicznej Polskiej Akademii Nauk1 064 400988 800NZ6
19.Fear of a pandemic. Biases in risk perception and risk taking in the time of coronavirusdr hab. Michał Krawczyk, prof. UWUniwersytet Warszawski323 697323 697HS4


Information on the proposals submitted and recommended for funding can be found below.

PanelNumber of proposals
submittedunder merit-based evaluationrecommended for funding


Please remember that the data presented is for information purposes only. The NCN Director will soon issue administrative decisions that will be then delivered to the applicants.